This program opens opportunities in enhancing statistical skills for validation projects, focusing on variance, sample distributions, and process capability, which are crucial for setting acceptance ...

Drug & Device Team provides recommendations based on Food & Drug Administration (FDA) draft guidance on Quality Management System ...

Over the last decade, technology-assisted review (TAR) has become a preferred choice in the e-discovery toolkit. Now, as ...

Hamilton Company brings decades of innovation in instrumentation and automation for laboratory and industrial applications. Its technology suite complements Alpha Controls’ service-driven model, which ...

Parallel development is here. See tactics to manage AI generated code variations, reduce PR clutter, and shift testing to ...

LifeStance Health reports on the viral "6-7" trend among kids, highlighting its role in fostering connection and emotional ...

Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their ...

Capital raised -- $17.1 million in new funding was secured, including a $13 million post-quarter investment from a leading ...

There is no doubt that sports fans want to feel safe at games, but they’re increasingly wary about how venues achieve that ...

The market opportunities lie in leveraging data process mapping to enhance data integrity and regulatory compliance, particularly aligning with FDA standards. There's potential in addressing gaps, ...

PolyPid Ltd. (NASDAQ: PYPD) Q3 2025 Earnings Call Transcript November 12, 2025 PolyPid Ltd. beats earnings expectations.